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Abstract- The European Directive 2013/35/UE sets the minimum requirements for the protection of 
workers exposed to electromagnetic fields and defines workers bearing implants as workers at 
particular risk. The European standards 50527-1 and 50527-2-1 propose risk assessments methods for 
these workers, including numerical and/or experimental in-vitro approaches. This study aims to 
conceive by using both methods, a cost-effective test bench for active cardiac implants in order to 
reproduce induced phenomena on a cardiac implant inside a human exposed to 50 Hz electric field, 
representing exposure up to 100 kV/m, which covers occupational exposure.  
Index terms: Electric Field, Low Frequency, Implanted Cardiac Defibrillators, Pacemaker, In-vitro EMC set-
up 
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I. INTRODUCTION 
The worldwide WHO (World Health Organization) report point out that cardiovascular diseases 
are principal major cause of death [1]. When the origin of pathology is a cardio-electrical system 
dysfunction, one of the possible clinical treatments is active cardiac device implantation: 
pacemaker (PM) or implantable cardiac defibrillator (ICD). Almost 4 million of active cardiac 
devices implantation had occurred from 1993 to 2009 only in USA, with an increase of 55% on 
implantation during these years [2]. For 2014, 8.4% of increase was estimated [3]. Furthermore, 
studies as cited ones underlines the increasing number of implantations, even to young and 
professionally active peoples. Electromagnetic fields may interact with active cardiac devices, 
causing some temporary dysfunction which may present health risks for implanted patient.  These 
facts cause a legal question: may a patient return to its previous job after implantation of an active 
cardiac implant, even if this occupational environment is electromagnetically exposed?   
The European Directive 2013/35/EU sets the minimum requirements for the protection of 
workers exposed to EMF fields, and defines workers bearing implants as workers at particular 
risk [4]. European standards 50527-1 and 50527-2-1 propose multiple risk assessments methods 
for these workers [5, 6]. The necessity of case by case studies is underlined due to the diversity of 
cases (implant model and settings, morphology and pathology of patient…). These methods 
include numerical or experimental in-vitro approaches. 
In the case of active cardiac implants and extremely low frequency electric or magnetic field, the 
risk for the workers could be due to the induction of voltage on the implant’s leads. Inductions 
inside the human body cannot be measured. Inductions of electric fields and/or currents have 
been treated by many scientists through numerical simulations on a virtual human body. 
However, few of them have conducted these studies taking into consideration medical active 
implants [7]. Moreover, few studies have compared the in vitro approaches, where an 
experimental homogeneous phantom is used, and the computational approaches [8]. This study 
describes a test bench to test active medical implants in a low frequency (50-60 Hz) E-field, by 
linking theoretical and experimental approaches. The objective is to develop a simple system, 
making possible to test cardiac active implants with electric field representative of occupational 
exposure, without requiring a huge voltage hall. 
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II. NUMERICAL METHODS 
Our in-vitro study aims to be as close as possible to in-vivo situation, by using computational 
methods to design a cost effective test bench and a phantom which has the same inductions then 
the heart area of a standing human grounded, which the worst case of coupling between 50/60 Hz 
electric field and human. Figure 1 illustrates the system that we have designed. Device under test 
(DUT) is exposed to external electric fields in an isolated test bench. The electric field is 
controlled by varying the voltage sources. 
 
Figure 1.  Test bench schematic 
Following parts explain the numerical methods and its validation via IEC 622226-3-1 [9]. The 
numerical conception of the experimental bench will be detailed and the choice of dimensions 
will be explained. 
 
a. Calculation Methods 
The electric and magnetic fields effects on human body can be separately studied at low 
frequency according to usual quasi-static approach. Analytical methods can be used to estimate 
the average inductions on human body, analyzing them in simplified geometric forms as semi-
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spheroidal, cylindrical or conical with simple homogeneous conductivity and permittivity values. 
These assumptions neglect the complex geometry of human body, moreover doesn’t take into 
account each organ’s specific dielectric properties. However, they are still used to make first 
estimation and validate the numerical method. 
Finite integration method is used with quasi-static assumptions derived from the Maxwell 
equations [10]. To resume these classical assumptions, time derivative of the magnetic field is 
neglected on the Faraday law to reduce the number of unknowns. As a consequence, the study 
domain is described by a complex scalar potential and discretized on tetrahedral meshes to 
represent more precisely the geometry. The human body proportions as well as the distance to the 
EMF source are very small compared to these wavelengths so the physical phenomena can be 
considered occurring instantly in every part of the domain. CST EM® software based on FIT 
method was used for our simulations in 3D. 
b. Validation of numerical methods 
From Maxwell's equations, one can deduce derived formulas for the analytical calculation of the 
induced currents in conductors by electro-quasi-static fields (1): 
 = 	 × 	 × 	
  (1) 
Jin is the current density induced within the conductive body, f is the frequency, Eex is the vertical 
external electric field and k is the shape factor depending on geometry, ratio of length to radius 
(L/R) of the body, and the location within the body where Jin is calculated.  
A homogeneous half ellipsoid phantom (σ = 0.2 S / m, grounded) as defined by the IEC 62226-3-
1 standard, was simulated for 50 Hz electric field and the same total current density is obtained 
with standard results derived from equation 1 (J = 0.134 mA/m², see Fig 2 a) [9]. The currents 
induced in the axis-symmetric model are numerically calculated with an error of 0.73% for the 
current density induction in the neck, comparing to results given in IEC 62226-3-1 [9]. The 
inductions curves announced by IEC and given by our simulations are shown on figure 2 (b,c). 
As the European Directive 2013/35/UE defines the inductions due to exposure in induced electric 
field (mV/m), we present our corresponding results deduced by ohm law in the following parts. 
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Figure 2. Current density induced on (1 kV/m 50 Hz): (a) spheroidal model (b) axisymmetric 
model (c) the analytical curve given by IEC 622226-3-1 (cross) compared to our simulation 
results (blue - no cross) for axisymmetric model [9] 
III. GENERATION OF ELECTRIC FIELD 
The objective is to develop an exposure system with parallel plan conductors that generates an 
electric field as uniform as possible in the test area to ensure the reproducibility and reliability of 
tests. A study domain for a human scale phantom in able to produce the uniform electric field is 
too large in experimental conditions, so it is not easy to realize with classical laboratory facilities. 
A smaller domain, with acceptable homogeneous field area, should be designed. Therefore, 
simulations with diverse dimensions of plan conductors are processed in order to classify the 
heterogeneity of the generated electric field, in an empty space as a first step.  
A curve of heterogeneity is showed at right-side of figure 3 in percent, following the vertical axis 
in the center of two parallel square electrodes. Here, the heterogeneity percentage is the deviance 
observed over the curve compare to the expected electric field.  The distance between two plates  
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Figure 3. Heterogeneity of electric field depending on dimensions of conductors planes 
(a) over the size of the squares (b) is the index a/b; and same index gives the same percentage of 
heterogeneity in empty space. Using the results and suitable dimensions obtained, we proceeded 
to simulations in an experimental room to conceive the conductor planes dimensions. Always 
considering equation 1, the amplitude of induced electric field will change only if the external 
field amplitude or shape factor of the object will change. As long as the object will stay 
identically, the amplitude of induced electric currents will be proportional to the external electric 
field. This linearity will allow us to design a reduced exposure system by applying a homothetic 
scale factor, in order to use it in an ordinary room (8.5 m x 6.8 m x 3.15 m in our case).  
Thus, electric field was calculated taking into account the geometry and the components (heaters, 
etc…) of the room. For 3D reconstruction of the room, all geometries and objects have been 
taken into account in simulations as well as their electrical properties. For obvious reasons, the 
system has to be big enough to accept the device under test. Thereby, the phantom in which the 
active implant will be placed has to have minimum dimensions versus exposure system. In our 
study, active cardiac implants are taken as a target; however same methods can be used for other 
active implants. According to EN 50527-2-1, the usual pacemaker lead is about 50 cm [6]. 
Always in same standard, maximum achievable realistic implant cardiac lead loop area is defined 
as 225cm² [6]. All taken into account, reduction of human body to 1/5 in height was the optimal 
solution. As a result, the study domain can also be miniaturized. Different dimensions of the 
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system were simulated to investigate the homogeneity of the field and their inductions to choose 
the best compromise (figure 4). 
 
 Figure 4. Induced electric fields inside spheroidal human body model, miniaturized to 1/5 and 
exposed to 1 kV/m with the test bench inside experimental room (CST simulations) 
In conclusion, two (2 m x 2 m x 0.002m) conductor plates, spaced by 75 cm, is the best 
compromise to simulate the exposition (figure 4). Other complementary simulations were done in 
order to investigate the experimental conditions, as material used (conductor planes, isolators, 
high voltage cables). Technical improvements have been made in order to reduce some negative 
effects (bending the edges, other upgrades related to ground). 
IV. ELECTROMAGNETIC PHANTOM 
Concerning in-vitro studies, one of the most common methods is based on a rectangular phantom 
for magnetic field exposure [11, 12]. However, due to the influence of the shape of the human 
body in an electric field, this rectangular shape cannot be used [9]. To experiment the effects of 
electric field exposition, the phantom should be designed numerically respecting the inductions 
occurring inside the human body. The induced electric field in the heart with and without cardiac 
implant was presented in a previous work [13] with an anatomical human body model (Ansoft). 
Our results for different organs are similar to other studies without implants [14, 15]. For 1 kV/m 
50Hz electric field, the maximum induced field over the heart is calculated as 4 mV/m and mean 
induced electric field over the thorax is calculated as 0.8 mV/m.  Those inductions are aimed to 
be reproduced in a numerically design experimental phantom.  
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The height of phantom is 35.2 cm, which is equivalent to 1/5 of human reference [16]. The 
phantom is miniaturized in order to be able to position it between the test bench conductor 
planes. However, it keeps the same circumference as a human thorax and is also able to contain a 
properly positioned cardiac implant. So the height is divided by 5 but if the radius stays 
unchanged, that will cause a significant decrease of the induction, impacting k which depends on 
L/R in equation 1. To counter this decrease, the radius had to diminish in order to increase the 
current density and the electric field. Once the induced electric field reaches those in human 
heart, the radius will be kept constant. For the reasons explained, our phantom looks like a funnel 
(Figure 5). 
The 35.2 cm highest phantom with 30 cm largest diameter (R4-Figure 5) of the cone has been 
simulated in order to define the radius which allows the imitation of human body inductions (R2-
Figure 5). The phantom is 3.3 mm thickness glass made, filled with a 0.2 S/m solution. The 
solution permittivity does not matter within the values between 100 and 107as mentioned in [9], 
and it has been verified by CST simulations. To assure the contact with earth, a metallic sole 
connected to ground is plugged to the cylindrical base. The higher part contains joints to stop the 
saline solution, compatible with cylinder. The bottom has been chosen larger enough (R1 = 120 
mm) to be able to keep the phantom in vertical position and connect it properly to ground (Figure 
5). A picture of experimental phantom is given in the left of figure 5. By simulations, we 
obtained that for (R4), with a full fill level (R3 = R4), the diameter cylinder has to be 54 mm 
(R2). 
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Figure 5. Experimental phantom filled with saline solution 
In that way, cylindrical part gives a constant electric field induction, representing maximum heart 
inductions (4 mV/m) which may contain the probe electrodes of a cardiac implant. The conic part 
is representing mean value of thorax inductions (0.8 mV/m) which may contain the box of 
implant. In figure 6, the induced electric field in coronal view at left-side and the induced electric 
field following vertical axes at right-side is showed.  
 
Figure 6. Induced electric fields inside the phantom with coronal view (left), following vertical 
axe (right) 
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V. DEVICE UNDER TEST 
The term device under test (DUT) in figure 1 represents in this study the cardiac implant inserted 
in the electromagnetic phantom. A cardiac implant is placed in the phantom to estimate 
numerically the interference voltages occurring over its probe tip. The figure 7 shows the 
implantation position and the induced electric field when the DUT is exposed to 1 kV/m 50 Hz. 
A 3 cm x 4 cm x 0.5 cm metallic box pacemaker with its lead and probe is installed mimicking a 
real case. The dimensions of the lead are respected as furnished in technical sheets from the 
manufacturer, with 10 mm tip to ring distance and 6.7 Fr cable diameter [17]. The probe 
characteristics are resumed at Figure 7. Further details about probe characteristics are mentioned 
in [18].  
 
Figure 7. Electric field induction inside the DUT exposed to 1 kV/m 50 Hz 
The induced voltages seen by cardiac implant vary depending on which mode of detection and 
configurations they are set. The most pertinent for this study is the two different detection modes: 
unipolar mode which uses the box as an electrode (anode) and probe as the other one (cathode), 
contrary to bipolar mode which employs two electrodes placed at the tip of the probe. For that 
reason, the detection curve also varies, making much important distance and much important 
interference voltages for unipolar detection, contrary to bipolar detection where this distance 
decreases considerably [13].  
If the induced electric field over the detection curve is plotted, the integral of this curve gives the 
induced voltage for the concerned detection mode. Figure 8 shows the induced electric field over 
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the detection curve of cardiac implant for both detection modes: unipolar (left) and bipolar 
(right).  
Under 1kV/m at 50 Hz electric field, implanted phantom simulations give interference voltages 
of 73 µV in bipolar detection and 550 µV in unipolar detection seen by the cardiac implant.  
 
Figure 8. Induced electric field over the detection curve of cardiac implant (1kV/m 50 Hz) 
 
VI. EXPERIMENTAL SETUP 
The experimental setup consists of a signal generator (Agilent®) delivering a pure 50 Hz sine 
wave which is amplified for driving a high voltage transformer up to 80 kV.  
The effective field generated between the conductor plates is measured by a 3D H/E field meter 
ESM-100 (Maschek). The maximum electric field measured at the center of the system is 100 
kV/m between two planes separated of 75 cm, for an applied voltage difference of 80 kV. The 
results presented on figure 9 on the right are obtained in the absence of the phantom. As the 
system is symmetric, the measurements with the field meter have been performed only in a 
quarter of the area, on a 25 cm grid step. Both electric field maps, numerically estimated and 
experimentally measured are shown in figure 8 for 20 kV/m applied. The maximum difference 
between the two results is about 1%. 
To ensure the reliability of electric field measurements, the room humidity is measured then 
controlled by the use of an air dryer. The temperature, humidity and the conductivity of the 
solution are recorded. Considering the dimensions of the experimental room, a simple 
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dehumidifier is enough to control the humidity in the room between 30-55%, and the 
temperatures do not vary much: from 19 to 28 degree Celsius. 
Figure 9 shows the transformer providing high voltage to the upper conductive plate and the 
yellow/green cable from the earth to the lower plate. The experimental phantom is placed as 
shown figure 10 on the left. The cardiac implants are connected to the same bipolar lead  
 
Figure 9. Experimental setup and electric field of the system 
respecting the type of device: defibrillator lead or pacing lead. To implant it into the phantom, the 
box is maintained by a small support. The probe is positioned in the middle of the cylindrical part 
where the field is homogenous.  
The solution has 0.19 – 0.21 S/m, and mixed to make it homogeneous inside all phantom, and 
checked by conductivity-meter. 
Before exposure, interrogation of implant settings and the lead impedance is tested inside the 
phantom via remote cardiac telemetry. Once the implementation process is completed, the 
experimental room is locked. The security is checked from the control room via motion sensors 
and camera, different values of the electric field have been settled to expose the experimental 
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phantom. The eventual dysfunctions that will occur will be recorded by the cardiac implant and 
retrieved via telemetry once the exposition will be finished. Figure 10 illustrates the exposure 
system and the interrogation after exposition of DUT. 
 
 
Figure 10.  Exposure and interrogation of DUT after exposure 
VII. DISCUSSION 
The test bench permits to reach 100 kV/m for 50 Hz and 83 kV/m for 60 Hz; they correspond to 
20 times the public limit (5 kV/m) proposed by ICNIRP 2010 [18]. Even for professional 
exposure, these fields are much higher than the exposure limit values proposed in 2013/35/EU, 
and the measures effectuated in professional environments in France [4,19]. Always according to 
the limits given by European directive, 10 times the low action level (10 kV/m) and 5 times the 
high action level (20 kV/m) are achieved [4]. These high levels would permit to test the 
immunity of active cardiac implants even in extreme conditions.  
Comparing to literature, with the test bench proposed in this paper, the conductivity homogeneity 
and the external field homogeneity is easier to reproduce and measure. The phantom weight is 
very light (7kg), comparing to human scale phantoms (≈200kg) making it easier to manipulate, 
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plus the control and the experimental rooms are separated and isolated [20-22]. Even when the 
DUT is exposed to maximum field (100kV/m) in the experimental room, the field measured in 
the control room is inferior to public limits (5 kV/m) according to ICNIRP 2010 [18]. Plus, the 
test bench is cost effective, not only for its construction but also the cost of each test effectuated. 
The external field may be varied to search a level of threshold in a uniform field, contrary to 
literature, where the aim is to test 3 range of non-uniform, in-situ electric field under lines. 
Additionally, that means the electric field is combined with magnetic field in such studies [21-
22]. Last but not least, the in-vivo studies are conducted recently by [23] with a statistically 
significant number of patient (110). To represent the external field, current injections by 
electrodes over patients have been use rather the real exposition, the methods are presented in 
[24]. There are many parameters as the morphology and the state of the patient, making it very 
complex to interpret the results and to compare the inductions in exposition and in current 
injection [25]. The in-vitro studies and numerical analyses are an indispensable tool to analyses 
the problems seen in in-vivo studies. 
Concerning DUT, the interference voltages are calculated for the two detection modes for active 
cardiac implants. The level of external electric field causing an induced interference voltage 
bigger then sensitivity voltage of the implant may be defined as threshold level. As the 
interference voltages are given per kV/m, we may estimate threshold levels of the cardiac implant 
depending on its sensitivity. Nevertheless, the values should be correlated to obtain the 
corresponding human exposition level. The interference voltages of an implanted virtual human 
body grounded has to be calculated. In that way, the external electric field dysfunction level of a 
cardiac implant for a grounded human may be obtained. As the maximum of heart inductions are 
taken into account for electromagnetic phantom, the numerical results in human body in same 
conditions are expected to be lesser. So, the thresholds (kV/m) would be greater than those of 
DUT.  
Another point, the in-vitro electric fields thresholds are expected to be greater than numerical 
estimations, because of various precautions taken against the electromagnetic interferences by 
implant manufacturers. Actually, all these precautions are subject of many patents and cannot be 
simulated entirely due to computational limits, lack of data and patent protection, which 
underlines the necessity of complementary in-vitro tests. 
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VIII. CONCLUSION 
Homogeneous conductivity phantoms are used in bioelectromagnetics to test EMF effects on 
cardiac implants [11, 20, 21]. In this study, we have designed an in vitro test bench for active 
implants, reproducing external exposure to electric fields at 50, up to 100 kV/m, which is higher 
than occupational exposure. This low cost design permits to test different medical devices 
without needing a huge high voltage hall. The conception of the phantom respects the electric 
field amplitudes occurring in human body. Moreover, the configuration has been chosen by 
taking into consideration the heart inductions for cardiac implants testing, especially bipolar 
detection. Unipolar detection tests are also available by the mean value of inductions. 
As perspective, in-vitro tests of cardiac implants would be realized with this test bench and 
electromagnetic phantom, in order to determine experimental thresholds. These are expected to 
be superior to the numerical ones. 
Different organs, morphologies and types of active medical implants could be tested with this test 
bench, simply by adapting the cylindrical part diameter of the phantom in order to reproduce 
concerned organ inductions.  
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